propranolol has been researched along with Tachycardia, Ventricular in 50 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
Tachycardia, Ventricular: An abnormally rapid ventricular rhythm usually in excess of 150 beats per minute. It is generated within the ventricle below the BUNDLE OF HIS, either as autonomic impulse formation or reentrant impulse conduction. Depending on the etiology, onset of ventricular tachycardia can be paroxysmal (sudden) or nonparoxysmal, its wide QRS complexes can be uniform or polymorphic, and the ventricular beating may be independent of the atrial beating (AV dissociation).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with bunazosin ameliorated this ischemia-related shortening of refractory periods at both the endo- and epicardial sites, with a greater effect seen epicardially (p < 0." | 5.30 | Differences in refractory-period response of canine subendocardium and subepicardium to bunazosin, an alpha1-adrenoceptor antagonist, and propranolol during myocardial ischemia. ( Handa, S; Iwamoto, T; Kusuzaki, S; Takigawa, O; Tanabe, T; Usui, K; Yoshitake, M, 1997) |
| "The effects of pretreatment with cariporide on myocardial infarction and ventricular arrhythmias in a rat model of ischemia/reperfusion were compared with those of nicorandil, propranolol, and nifedipine." | 3.72 | Effects of cariporide (HOE642) on myocardial infarct size and ventricular arrhythmias in a rat ischemia/reperfusion model: comparison with other drugs. ( Beguier, B; Wajima, T; Yaguchi, M, 2004) |
| " Prenatal treatment with beta-adrenergic blocker (propranolol) and digitalis glycosides was prescribed because of suspicion of long QT syndrome occurring with fetal congestive heart failure." | 3.71 | Prenatal diagnosis and treatment of fetal long QT syndrome: a case report. ( Chang, IK; Chow, SN; Hsieh, FJ; Kau, ML; Ko, YH; Lee, CN; Shyu, MK, 2002) |
| "The proarrhythmic effects of 3-hydroxy-hydroquinidine (3-OH-HQ) and quinidine were compared in a canine model of QT-dependent ventricular arrhythmias." | 3.69 | Proarrhythmic effects of a quinidine analog in dogs with chronic A-V block. ( Cheymol, G; Chézalviel-Guilbert, F; Davy, JM; Guhennec, C; Poirier, JM; Weissenburger, J, 1995) |
| " In hyperthyroidism late potentials may be eliminated rapidly by propranolol even in low dosages." | 3.69 | [Late potentials in high resolution ECG in thyroid gland dysfunction]. ( Buchinger, W; Eber, O; Költringer, P; Schippinger, W; Schubert, B, 1995) |
| "The use of propranolol is generally contraindicated in patients with congestive heart failure." | 3.68 | Successful treatment of life-threatening ventricular tachycardia with high-dose propranolol under extracorporeal life support and intraaortic balloon pumping. ( Goto, H; Kurose, M; Ogata, K; Okamoto, K; Okumura, K; Sato, T; Terasaki, H; Yasumoto, M; Yatsuda, R, 1993) |
| "Verapamil was more effective than the dihydropyridine L-type Ca(2+) channel blocker nifedipine, and its activity was markedly enhanced when combined with propranolol." | 2.75 | Optimizing catecholaminergic polymorphic ventricular tachycardia therapy in calsequestrin-mutant mice. ( Arad, M; Eldar, M; Hochhauser, E; Katz, G; Khoury, A; Kurtzwald, E; Lorber, A; Porat, E; Seidman, CE; Seidman, JG; Shainberg, A, 2010) |
| "Idiopathic left ventricular tachycardia (VT) has been classified into three subgroups according to mechanism: verapamil-sensitive, adenosine-sensitive, and propranolol-sensitive types." | 2.41 | Idiopathic left ventricular tachycardia: assessment and treatment. ( Nogami, A, 2002) |
| "The most common form of idiopathic ventricular tachycardia originates from the right ventricular outflow tract, is characterized by sensitivity to adenosine, and appears to be due to cyclic AMP-mediated triggered activity." | 2.41 | Management of ventricular tachycardia in patients with clinically normal hearts. ( Iwai, S; Lerman, BB, 2000) |
| "Polymorphic ventricular tachycardia (PMVT) is a rare genetic disease associated with structurally normal hearts which in 8% of cases can lead to sudden cardiac death, typically exercise-induced." | 1.91 | Personalized medicine in the dish to prevent calcium leak associated with short-coupled polymorphic ventricular tachycardia in patient-derived cardiomyocytes. ( Charrabi, A; Chen, S; Cheung, JW; Colombani, S; Evans, T; Jaffré, F; Lacampagne, A; Lerman, BB; Marks, AR; Meli, AC; Pasquié, JL; Reiken, S; Sittenfeld, LR; Sleiman, Y, 2023) |
| "Leptin has been proposed to modulate cardiac electrical properties via β-adrenergic receptor activation." | 1.42 | Leptin decreases heart rate associated with increased ventricular repolarization via its receptor. ( Davis, M; Hileman, S; Huang, J; Hull, R; Lin, YC; Martin, KH; Yu, HG, 2015) |
| "Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a familial arrhythmic syndrome caused by mutations in genes encoding the calcium-regulation proteins cardiac ryanodine receptor (RyR2) or calsequestrin-2 (CASQ2)." | 1.37 | Prevention of ventricular arrhythmia and calcium dysregulation in a catecholaminergic polymorphic ventricular tachycardia mouse model carrying calsequestrin-2 mutation. ( Alcalai, R; Arad, M; Berul, CI; Konno, T; Planer, D; Seidman, CE; Seidman, JG; Wakimoto, H; Wang, L, 2011) |
| "Monomorphic ventricular tachycardia (VT) is a unique manifestation of hyperthyroidism." | 1.36 | Repetitive monomorphic ventricular tachycardia as a manifestation of suboptimally treated thyrotoxicosis. ( Chandra, AB; Chandra, PA; Ghosh, J; Pednekar, M; Vallakati, A, 2010) |
| "Catecholaminergic polymorphic ventricular tachycardia occurs in healthy children and young adults causing syncope and sudden cardiac death." | 1.35 | Catecholaminergic polymorphic ventricular tachycardia: a current overview. ( Barreto, JR; Cruz Filho, FE; Fenelon, G; Henz, BD; Leite, LR; Macedo, PG; Santos, SN; Zanatta, A, 2009) |
| "Ventricular premature beats frequently originated from the peri-infarct zone, and 37% showed elevation of Ca(i) prior to V(m) depolarization, suggesting reverse excitation-contraction coupling as their aetiology." | 1.34 | Remodelling of action potential and intracellular calcium cycling dynamics during subacute myocardial infarction promotes ventricular arrhythmias in Langendorff-perfused rabbit hearts. ( Chen, PS; Chou, CC; Fishbein, MC; Hayashi, H; Lin, SF; Liu, YB; Nihei, M; Weiss, JN; Wen, MS; Wu, D; Yeh, SJ; Zhou, S, 2007) |
| "Recurrent life-threatening episodes of ventricular tachycardia persisted despite maximal antiarrhythmic theraphy with amiodarone, metoprolol and mexiletine." | 1.33 | Suppression by propranolol and amiodarone of an electrical storm refractory to metoprolol and amiodarone. ( Anastasiou-Nana, MI; Kanakakis, J; Rokas, S; Tsagalou, EP, 2005) |
| "Idiopathic ventricular tachycardia is rare, especially in infants." | 1.32 | Verapamil sensitive idiopathic ventricular tachycardia in an infant. ( Chi, CS; Fu, YC; Jan, SL; Wang, JD, 2003) |
| "Catecholaminergic polymorphic ventricular tachycardia (VT) is a rare arrhythmogenic disorder, which may cause sudden death and whose relationships with mutations in cardiac ryanodine receptor gene have been recently established." | 1.32 | Catecholaminergic polymorphic ventricular tachycardia: successful emergency treatment with intravenous propranolol. ( Bloise, R; Chiaretti, A; De Rosa, G; Delogu, AB; Piastra, M; Priori, SG, 2004) |
| "Propranolol or flecainide was added to the treatment protocol for two patients who did not respond to verapamil alone." | 1.31 | Idiopathic sustained left ventricular tachycardia in pediatric patients. ( Iwamoto, M; Kobayashi, H; Niimura, I; Nishizawa, T; Sakon, T; Shibata, T; Takigiku, K; Yasui, K; Yokoyama, U, 2001) |
| "Treatment with bunazosin ameliorated this ischemia-related shortening of refractory periods at both the endo- and epicardial sites, with a greater effect seen epicardially (p < 0." | 1.30 | Differences in refractory-period response of canine subendocardium and subepicardium to bunazosin, an alpha1-adrenoceptor antagonist, and propranolol during myocardial ischemia. ( Handa, S; Iwamoto, T; Kusuzaki, S; Takigawa, O; Tanabe, T; Usui, K; Yoshitake, M, 1997) |
| "Propranolol hydrochloride was administered to 30 patients with stable angina pectoris suffering from coronary heart disease (CHD)." | 1.29 | [The characteristics of the autonomic regulation of the heart rate in patients with IHD and ventricular arrhythmias under obzidan therapy]. ( Afonskaia, NI; Belogubets, VI; Polevaia, TIu; Smetnev, AS, 1994) |
| "Dogs with an inherited predisposition to sudden death display ventricular arrhythmias having certain characteristics, such as pause dependence, that are suggestive of early afterdepolarization-induced triggered activity." | 1.29 | Phenylephrine-induced ventricular arrhythmias in dogs with inherited sudden death. ( Brittain, D; Flahive, WJ; Gilmour, RF; Lee, RJ; Lewis, BA; Moïse, NS; Moon, PF; Pride, HP; Zipes, DP, 1996) |
| "Exercise-induced ventricular tachycardia (VT) without demonstrable heart disease was studied in pediatric patients." | 1.29 | Exercise-induced ventricular tachycardia without demonstrable heart disease in childhood. ( Baba, R; Goto, M; Nagano, Y; Nagashima, M; Nishabata, K, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 22 (44.00) | 18.2507 |
| 2000's | 16 (32.00) | 29.6817 |
| 2010's | 8 (16.00) | 24.3611 |
| 2020's | 4 (8.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sun, Q | 1 |
| Wang, F | 1 |
| Zheng, R | 1 |
| Xie, Z | 1 |
| Jia, L | 1 |
| Li, D | 1 |
| Sleiman, Y | 1 |
| Reiken, S | 1 |
| Charrabi, A | 1 |
| Jaffré, F | 1 |
| Sittenfeld, LR | 1 |
| Pasquié, JL | 1 |
| Colombani, S | 1 |
| Lerman, BB | 2 |
| Chen, S | 1 |
| Marks, AR | 1 |
| Cheung, JW | 1 |
| Evans, T | 1 |
| Lacampagne, A | 1 |
| Meli, AC | 1 |
| Kusayama, T | 1 |
| Chen, PS | 2 |
| Vaksmann, G | 1 |
| Lucidarme, S | 1 |
| Henriet, E | 1 |
| Cafferkey, A | 1 |
| McMahon, C | 1 |
| Nagatome, Y | 1 |
| Ueno, K | 1 |
| Takahashi, Y | 1 |
| Hazeki, D | 1 |
| Kawano, Y | 1 |
| Puljević, M | 1 |
| Velagić, V | 1 |
| Puljević, D | 1 |
| Miličić, D | 1 |
| Lin, YC | 1 |
| Huang, J | 1 |
| Hileman, S | 1 |
| Martin, KH | 1 |
| Hull, R | 1 |
| Davis, M | 1 |
| Yu, HG | 1 |
| Leite, LR | 1 |
| Henz, BD | 1 |
| Macedo, PG | 1 |
| Santos, SN | 1 |
| Barreto, JR | 1 |
| Zanatta, A | 1 |
| Fenelon, G | 1 |
| Cruz Filho, FE | 1 |
| Katz, G | 1 |
| Khoury, A | 1 |
| Kurtzwald, E | 1 |
| Hochhauser, E | 1 |
| Porat, E | 1 |
| Shainberg, A | 1 |
| Seidman, JG | 2 |
| Seidman, CE | 2 |
| Lorber, A | 1 |
| Eldar, M | 2 |
| Arad, M | 2 |
| Alcalai, R | 1 |
| Wakimoto, H | 1 |
| Planer, D | 1 |
| Konno, T | 1 |
| Wang, L | 1 |
| Berul, CI | 1 |
| Chandra, PA | 1 |
| Vallakati, A | 1 |
| Chandra, AB | 1 |
| Pednekar, M | 1 |
| Ghosh, J | 1 |
| de Oliveira, FC | 1 |
| Feitosa-Filho, GS | 1 |
| Ritt, LE | 1 |
| Nogami, A | 1 |
| Chang, IK | 1 |
| Shyu, MK | 1 |
| Lee, CN | 1 |
| Kau, ML | 1 |
| Ko, YH | 1 |
| Chow, SN | 1 |
| Hsieh, FJ | 1 |
| Pras, E | 1 |
| Lahat, H | 1 |
| Wang, JD | 1 |
| Fu, YC | 1 |
| Jan, SL | 1 |
| Chi, CS | 1 |
| Wajima, T | 1 |
| Beguier, B | 1 |
| Yaguchi, M | 1 |
| Tassone, H | 1 |
| Moulin, A | 1 |
| Henderson, SO | 1 |
| De Rosa, G | 1 |
| Delogu, AB | 1 |
| Piastra, M | 1 |
| Chiaretti, A | 1 |
| Bloise, R | 1 |
| Priori, SG | 1 |
| Tsagalou, EP | 1 |
| Kanakakis, J | 1 |
| Rokas, S | 1 |
| Anastasiou-Nana, MI | 1 |
| Komiya, N | 1 |
| Seto, S | 1 |
| Nakao, K | 1 |
| Yano, K | 1 |
| Hayashi, M | 1 |
| Okazaki, H | 1 |
| Igei, S | 1 |
| Inada, K | 1 |
| Matuo, S | 1 |
| Date, T | 1 |
| Yagi, H | 1 |
| Yamane, T | 1 |
| Sugimoto, K | 1 |
| Mochizuki, S | 1 |
| Chou, CC | 1 |
| Zhou, S | 1 |
| Hayashi, H | 3 |
| Nihei, M | 1 |
| Liu, YB | 1 |
| Wen, MS | 1 |
| Yeh, SJ | 1 |
| Fishbein, MC | 1 |
| Weiss, JN | 1 |
| Lin, SF | 1 |
| Wu, D | 1 |
| Yamawake, N | 1 |
| Nishizaki, M | 1 |
| Hayashi, T | 1 |
| Niki, S | 1 |
| Maeda, S | 1 |
| Tanaka, Y | 1 |
| Fujii, H | 1 |
| Ashikaga, T | 1 |
| Sakurada, H | 1 |
| Hiraoka, M | 1 |
| Stengl, M | 1 |
| Aronow, WS | 2 |
| Ahn, C | 2 |
| Mercando, AD | 2 |
| Epstein, S | 2 |
| Kronzon, I | 2 |
| Stramba-Badiale, M | 1 |
| Lazzarotti, M | 1 |
| Facchini, M | 1 |
| Schwartz, PJ | 1 |
| Belogubets, VI | 1 |
| Polevaia, TIu | 1 |
| Afonskaia, NI | 1 |
| Smetnev, AS | 1 |
| Chézalviel-Guilbert, F | 1 |
| Weissenburger, J | 1 |
| Davy, JM | 1 |
| Guhennec, C | 1 |
| Poirier, JM | 1 |
| Cheymol, G | 1 |
| Peuhkurinen, KJ | 1 |
| Huikuri, HV | 1 |
| Linnaluoto, M | 1 |
| Takkunen, JT | 1 |
| McCurdy, CM | 1 |
| Rutherford, SE | 1 |
| Coddington, CC | 1 |
| Kurose, M | 1 |
| Okamoto, K | 1 |
| Sato, T | 1 |
| Yatsuda, R | 1 |
| Ogata, K | 1 |
| Yasumoto, M | 1 |
| Terasaki, H | 1 |
| Goto, H | 1 |
| Okumura, K | 1 |
| Bélichard, P | 1 |
| Savard, P | 1 |
| Cardinal, R | 1 |
| Nadeau, R | 1 |
| Gosselin, H | 1 |
| Paradis, P | 1 |
| Rouleau, JL | 1 |
| Ishibashi, H | 1 |
| Fu, L | 1 |
| Namiki, T | 1 |
| Sekiguchi, A | 1 |
| Sagara, K | 1 |
| Kato, K | 1 |
| Twidale, N | 1 |
| Rayner, TE | 1 |
| Menadue, MF | 1 |
| Cain, MD | 1 |
| Tonkin, AM | 1 |
| Oliver, JR | 1 |
| Gautam, CS | 1 |
| Sharma, PL | 1 |
| Pandhi, P | 1 |
| Schippinger, W | 1 |
| Buchinger, W | 1 |
| Schubert, B | 1 |
| Költringer, P | 1 |
| Eber, O | 1 |
| Moïse, NS | 1 |
| Moon, PF | 1 |
| Flahive, WJ | 1 |
| Brittain, D | 1 |
| Pride, HP | 1 |
| Lewis, BA | 1 |
| Zipes, DP | 1 |
| Lee, RJ | 1 |
| Gilmour, RF | 1 |
| Nagashima, M | 1 |
| Baba, R | 1 |
| Goto, M | 1 |
| Nishabata, K | 1 |
| Nagano, Y | 1 |
| Fujiki, A | 2 |
| Tani, M | 2 |
| Mizumaki, K | 2 |
| Shimono, M | 2 |
| Inoue, H | 2 |
| Tanabe, T | 2 |
| Usui, K | 2 |
| Kusuzaki, S | 1 |
| Yoshitake, M | 1 |
| Takigawa, O | 1 |
| Iwamoto, T | 1 |
| Handa, S | 2 |
| Usui, M | 1 |
| Nagasawa, H | 1 |
| Shinozaki, Y | 1 |
| Mori, H | 1 |
| Zahedi, A | 1 |
| Grant, MH | 1 |
| Wong, DT | 1 |
| Fisher, JD | 1 |
| Krikler, D | 1 |
| Hallidie-Smith, KA | 1 |
| Kou, WH | 1 |
| Man, KC | 1 |
| Goyal, R | 1 |
| Strickberger, SA | 1 |
| Morady, F | 1 |
| Iwai, S | 1 |
| Yasui, K | 1 |
| Shibata, T | 1 |
| Yokoyama, U | 1 |
| Nishizawa, T | 1 |
| Takigiku, K | 1 |
| Sakon, T | 1 |
| Kobayashi, H | 1 |
| Iwamoto, M | 1 |
| Niimura, I | 1 |
4 reviews available for propranolol and Tachycardia, Ventricular
| Article | Year |
|---|---|
Use of beta-blockers for the treatment of cardiac arrest due to ventricular fibrillation/pulseless ventricular tachycardia: a systematic review.
Topics: Adrenergic beta-Antagonists; Animals; Cardiopulmonary Resuscitation; Coronary Circulation; Epinephri | 2012 |
Idiopathic left ventricular tachycardia: assessment and treatment.
Topics: Adenosine; Anti-Arrhythmia Agents; Body Surface Potential Mapping; Catheter Ablation; Electrocardiog | 2002 |
The pitfalls of potassium replacement in thyrotoxic periodic paralysis: a case report and review of the literature.
Topics: Adult; Anti-Arrhythmia Agents; Emergency Medical Services; Humans; Hyperkalemia; Hyperthyroidism; Hy | 2004 |
Management of ventricular tachycardia in patients with clinically normal hearts.
Topics: Adenosine; Anti-Arrhythmia Agents; Catheter Ablation; Electrocardiography; Female; Heart Function Te | 2000 |
3 trials available for propranolol and Tachycardia, Ventricular
| Article | Year |
|---|---|
Optimizing catecholaminergic polymorphic ventricular tachycardia therapy in calsequestrin-mutant mice.
Topics: Adolescent; Adult; Animals; Anti-Arrhythmia Agents; Child; Female; Humans; Male; Mice; Mice, Transge | 2010 |
Effect of propranolol versus no antiarrhythmic drug on sudden cardiac death, total cardiac death, and total death in patients > or = 62 years of age with heart disease, complex ventricular arrhythmias, and left ventricular ejection fraction > or = 40%.
Topics: Aged; Aged, 80 and over; Cardiac Complexes, Premature; Death, Sudden, Cardiac; Echocardiography; Ele | 1994 |
Decrease in mortality by propranolol in patients with heart disease and complex ventricular arrhythmias is more an anti-ischemic than an antiarrhythmic effect.
Topics: Aged; Aged, 80 and over; Coronary Disease; Humans; Middle Aged; Propranolol; Prospective Studies; Si | 1994 |
43 other studies available for propranolol and Tachycardia, Ventricular
| Article | Year |
|---|---|
[Clinical and genetic analysis of five children with Catecholaminergic polymorphic ventricular tachycardia due to variants of RYR2 gene].
Topics: Child; Humans; Mutation; Propranolol; Ryanodine Receptor Calcium Release Channel; Syncope; Tachycard | 2023 |
Personalized medicine in the dish to prevent calcium leak associated with short-coupled polymorphic ventricular tachycardia in patient-derived cardiomyocytes.
Topics: Anti-Arrhythmia Agents; Calcium; Flecainide; Humans; Myocytes, Cardiac; Precision Medicine; Proprano | 2023 |
Propranolol or SGB, That Is the Question.
Topics: Arrhythmias, Cardiac; Autonomic Nerve Block; Humans; Propranolol; Stellate Ganglion; Tachycardia, Ve | 2020 |
Fetal ventricular tachycardia: betablockers should be the first line treatment.
Topics: Adrenergic beta-Antagonists; Adult; Diuretics; Female; Fetal Diseases; Fetal Monitoring; Humans; Inf | 2021 |
Successful Treatment of Refractory Cardiac Arrest With β-Blockade and Extracorporeal Life Support in a Pediatric Patient With Catecholaminergic Polymorphic Ventricular Tachycardia: A Case Report.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Atenolo | 2018 |
Neonatal ventricular tachycardia: Adverse event possibly due to maternal ritodrine.
Topics: Adult; Anti-Arrhythmia Agents; Electrocardiography; Female; Humans; Infant, Newborn; Male; Pregnancy | 2019 |
Propranolol efficiency in prevention of sustained ventricular tachycardia in patients with implanted cardioverter-defibrillator: a case series.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Defibrillators, Implantable; Female; Humans; M | 2014 |
Leptin decreases heart rate associated with increased ventricular repolarization via its receptor.
Topics: Action Potentials; Adrenergic beta-Antagonists; Animals; Electrophysiological Phenomena; Heart; Hear | 2015 |
Catecholaminergic polymorphic ventricular tachycardia: a current overview.
Topics: Adrenergic beta-Antagonists; Child; Diagnosis, Differential; Dose-Response Relationship, Drug; Elect | 2009 |
Prevention of ventricular arrhythmia and calcium dysregulation in a catecholaminergic polymorphic ventricular tachycardia mouse model carrying calsequestrin-2 mutation.
Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Calcium Channel Blockers; Calcium Sign | 2011 |
Repetitive monomorphic ventricular tachycardia as a manifestation of suboptimally treated thyrotoxicosis.
Topics: Adrenergic beta-Antagonists; Adult; Antithyroid Agents; Humans; Male; Methimazole; Propranolol; Tach | 2010 |
Prenatal diagnosis and treatment of fetal long QT syndrome: a case report.
Topics: Adult; Bradycardia; Bundle-Branch Block; Electrocardiography; Female; Fetal Diseases; Heart Block; H | 2002 |
A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel.
Topics: Adrenergic beta-Antagonists; Base Sequence; Calsequestrin; Catecholamines; Child; Child, Preschool; | 2002 |
Verapamil sensitive idiopathic ventricular tachycardia in an infant.
Topics: Amiodarone; Anti-Arrhythmia Agents; Drug Resistance; Drug Therapy, Combination; Electrocardiography; | 2003 |
Effects of cariporide (HOE642) on myocardial infarct size and ventricular arrhythmias in a rat ischemia/reperfusion model: comparison with other drugs.
Topics: Animals; Anti-Arrhythmia Agents; Blood Pressure; Dose-Response Relationship, Drug; Electrocardiograp | 2004 |
Catecholaminergic polymorphic ventricular tachycardia: successful emergency treatment with intravenous propranolol.
Topics: Adrenergic beta-Antagonists; Brain Edema; Catecholamines; Child; Decerebrate State; Electrocardiogra | 2004 |
Suppression by propranolol and amiodarone of an electrical storm refractory to metoprolol and amiodarone.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Defibrillator | 2005 |
The influence of beta-adrenergic agonists and antagonists on T-wave alternans in patients with and without ventricular tachyarrhythmia.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Electrocardiography; Female; Humans; Isoprote | 2005 |
[Catecholaminergic polymorphic ventricular tachycardia successfully treated by beta blocker].
Topics: Adolescent; Adrenergic beta-Antagonists; Catecholamines; Female; Humans; Isoproterenol; Propranolol; | 2006 |
Remodelling of action potential and intracellular calcium cycling dynamics during subacute myocardial infarction promotes ventricular arrhythmias in Langendorff-perfused rabbit hearts.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Calcium; Cardiac Complexes | 2007 |
Autonomic and pharmacological responses of idiopathic ventricular tachycardia arising from the left ventricular outflow tract.
Topics: Adenosine Triphosphate; Anti-Arrhythmia Agents; Cardiotonic Agents; Catheter Ablation; Electrophysio | 2007 |
What is more dangerous in long QT 3 syndrome? Arrhythmogenic trigger or substrate?
Topics: Animals; Anti-Arrhythmia Agents; Cardiac Electrophysiology; Electric Stimulation; Long QT Syndrome; | 2008 |
Malignant arrhythmias and acute myocardial ischemia: interaction between flecainide and the autonomic nervous system.
Topics: Animals; Autonomic Nervous System; Cardiac Complexes, Premature; Cats; Electrocardiography; Flecaini | 1994 |
[The characteristics of the autonomic regulation of the heart rate in patients with IHD and ventricular arrhythmias under obzidan therapy].
Topics: Adult; Aged; Analysis of Variance; Autonomic Nervous System; Cardiac Complexes, Premature; Drug Eval | 1994 |
Proarrhythmic effects of a quinidine analog in dogs with chronic A-V block.
Topics: Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Dogs; Elec | 1995 |
Changes in myocardial metabolism and transcardiac electrolytes during simulated ventricular tachycardia: effects of beta-adrenergic blockade.
Topics: Adenine Nucleotides; Blood Pressure; Carbon Dioxide; Cardiac Pacing, Artificial; Coronary Disease; C | 1994 |
Syncope and sudden arrhythmic death complicating pregnancy. A case report of Romano-Ward syndrome.
Topics: Adrenergic beta-Antagonists; Adult; Bradycardia; Cesarean Section; Death, Sudden, Cardiac; Electric | 1993 |
Successful treatment of life-threatening ventricular tachycardia with high-dose propranolol under extracorporeal life support and intraaortic balloon pumping.
Topics: Combined Modality Therapy; Extracorporeal Circulation; Heart Failure; Humans; Intra-Aortic Balloon P | 1993 |
Markedly different effects on ventricular remodeling result in a decrease in inducibility of ventricular arrhythmias.
Topics: Animals; Captopril; Cardiac Pacing, Artificial; Hypertrophy, Left Ventricular; Male; Myocardial Infa | 1994 |
Induction and the possible mechanism of ventricular tachycardia after catheter ablation with direct current shocks in dogs.
Topics: Animals; Bundle of His; Cardiac Pacing, Artificial; Catheter Ablation; Dogs; Electrocardiography, Am | 1993 |
Atrial natriuretic factor release during rapid ventricular pacing: interplay between autonomic and hemodynamic stimulants.
Topics: Adult; Atrial Natriuretic Factor; Atropine; Autonomic Nervous System; Blood Pressure; Cardiac Pacing | 1993 |
Differential effect of selected antiarrhythmic drugs on coronary artery ligation-induced ventricular arrhythmias on the right or left sides.
Topics: Animals; Anti-Arrhythmia Agents; Coronary Disease; Disease Models, Animal; Dogs; Female; Ligation; M | 1995 |
[Late potentials in high resolution ECG in thyroid gland dysfunction].
Topics: Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Electrocardiography; Humans; Hyperthyroidism; | 1995 |
Phenylephrine-induced ventricular arrhythmias in dogs with inherited sudden death.
Topics: Animals; Atropine; Cardiac Pacing, Artificial; Death, Sudden; Dogs; Female; Genetic Predisposition t | 1996 |
Exercise-induced ventricular tachycardia without demonstrable heart disease in childhood.
Topics: Adolescent; Age Factors; Anti-Arrhythmia Agents; Child; Electrocardiography, Ambulatory; Exercise; E | 1996 |
Role of sympathovagal balance in the initiation of idiopathic ventricular tachycardia originating from right ventricular outflow tract.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Bundle-Branch Block; Female; Heart Rate; Human | 1997 |
Differences in refractory-period response of canine subendocardium and subepicardium to bunazosin, an alpha1-adrenoceptor antagonist, and propranolol during myocardial ischemia.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; | 1997 |
Circadian variation of idiopathic ventricular tachycardia originating from right ventricular outflow tract.
Topics: Adult; Anti-Arrhythmia Agents; Circadian Rhythm; Electrocardiography, Ambulatory; Female; Heart Rate | 1999 |
Disproportional response between refractory period and blood flow to alpha 1- and beta-adrenoceptor blockade in canine ischemic myocardium.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; | 1998 |
Successful treatment of chloral hydrate cardiac toxicity with propranolol.
Topics: Adult; Anti-Arrhythmia Agents; Chloral Hydrate; Humans; Hypnotics and Sedatives; Male; Propranolol; | 1999 |
Familial polymorphic ventricular arrhythmias: a quarter century of successful medical treatment based on serial exercise-pharmacologic testing.
Topics: Adolescent; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Anti-Arrhythmia Agents; An | 1999 |
Interaction between autonomic tone and the negative chronotropic effect of adenosine in humans.
Topics: Adenosine; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Atropine; | 1999 |
Idiopathic sustained left ventricular tachycardia in pediatric patients.
Topics: Adolescent; Anti-Arrhythmia Agents; Child; Child, Preschool; Electrophysiology; Female; Flecainide; | 2001 |